Search

everythinglearnresearchcommunity

for

Search:↓

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Bicalutamide may help treat female pattern hair loss.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Physical activity, height, and smoking affect prostate cancer risk.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Higher DHT in male baldness may protect against prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Early balding at 40 increases prostate cancer risk.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.